cephalosporin c has been researched along with trovafloxacin in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (58.82) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 1 (5.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maskell, JP; Minassian, M; Sefton, AM; Seymour, AC; Williams, JD | 1 |
Brück, W; Fischer, FR; Nau, R; Schmidt, H; Stringaris, AK; Stuertz, K; Zysk, G | 1 |
Friedland, IR; Lutsar, I | 1 |
Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR | 1 |
Deschilder, I; Liekens, K; Lontie, M | 1 |
Johnson, DM; Jones, RN; Pfaller, MA | 1 |
Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
Friedland, IR; Ghaffar, F; Jafri, H; Lutsar, I; McCracken, GH; Ng, W; Wubbel, L | 1 |
Bingen, E; Doit, C; Fitoussi, F; Geslin, P | 1 |
Eiffert, H; Mäder, M; Nau, R; Schmidt, H; Stuertz, K; Trostdorf, F | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Neftel, K; Täuber, MG | 1 |
Bonapace, CR; Bosso, JA; Friedrich, LV; White, RL | 1 |
Anolik, JH; Cohn, SE; Marquardt, JD; Totterman, S; Wildy, K; Zwillich, SH | 1 |
Arguedas, AG; Arrieta, AC; Bradley, J; Falleiros-Carvalho, LH; Feris, JM; Frenck, RW; Hussey, GD; Klugman, KP; Marques, SR; McCoig, C; McCracken, GH; Pancorbo, S; Sáez-Llorens, X; Vargas, SL; Wald, ER | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Borner, K; Brodersen, B; Koeppe, P; Lode, H; Lubasch, A; Ziege, S | 1 |
Srinivas, NR | 1 |
1 review(s) available for cephalosporin c and trovafloxacin
Article | Year |
---|---|
New antibiotics.
Topics: Anti-Infective Agents; Cefepime; Cephalosporins; Child; Fluoroquinolones; Humans; Meningitis, Bacterial; Meropenem; Naphthyridines; Thienamycins | 1998 |
2 trial(s) available for cephalosporin c and trovafloxacin
Article | Year |
---|---|
Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Infant; Infusions, Intravenous; Liver; Male; Meningitis, Bacterial; Naphthyridines; Seizures; Treatment Outcome | 2002 |
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefepime; Cephalosporins; Cross-Over Studies; Female; Fluoroquinolones; Humans; Male; Naphthyridines | 2003 |
14 other study(ies) available for cephalosporin c and trovafloxacin
Article | Year |
---|---|
Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Fluoroquinolones; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Penicillins; Streptococcus pneumoniae; Streptococcus pyogenes | 1996 |
Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
Topics: Adult; Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Humans; Injections, Intravenous; Interleukin-1; Lactic Acid; Meningitis, Pneumococcal; Naphthyridines; Rabbits; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha | 1997 |
Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Drug Synergism; Fluoroquinolones; Humans; Naphthyridines; Penicillin Resistance; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin | 1998 |
In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Cephalosporins; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Outpatients; Penicillin G; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Roxithromycin; Streptococcus pneumoniae | 1998 |
Antimicrobial interactions of trovafloxacin and extended-spectrum cephalosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Topics: Anti-Infective Agents; Azithromycin; Cephalosporins; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas aeruginosa; Xanthomonas | 1998 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Naphthyridines; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1999 |
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievab
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cephalosporin Resistance; Cephalosporins; Drug Interactions; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Streptococcus pneumoniae; Vancomycin | 1999 |
Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Immunoenzyme Techniques; Lipopolysaccharides; Meningitis, Pneumococcal; Moxifloxacin; Naphthyridines; Polysaccharides, Bacterial; Quinolines; Rabbits; Reference Values; Rifabutin; Teichoic Acids; Virginiamycin | 1999 |
Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae | 2000 |
Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Piperacillin; Reproducibility of Results; Tobramycin | 2000 |
Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis.
Topics: Anti-Infective Agents; Arthritis, Infectious; Cefazolin; Cephalosporins; Drug Therapy, Combination; Fluoroquinolones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naphthyridines; Rifampin; Sacroiliac Joint; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin | 2016 |